On Thursday, the European Medicines Agency (EMA) declared that the present monkeypox outbreak in Europe is “not a public health crisis” at this time. The European Medicines Agency’s head of biological health threats and vaccines strategy, Marco Cavaleri, stated the danger for the general public to become infected with the virus is low, and that even if there is an increase in cases, no major surge is anticipated.”
“The main objective should be the detection, monitoring, and management of new monkeypox cases,” Cavaleri said. Furthermore, Cavaleri noted, “It’s unusual for a monkeypox outbreak to have such a broad geographic distribution,” but “the majority of sufferers had benign symptoms and healed without the need of medication.”
The EMA is taking action out of an abundance of caution in order to provide choices for preventing and treating the illness if required, he added. The World Health Organization’s (WHO) director on Wednesday said that thirty non-endemic nations have reported over 550 verified monkeypox infections.
“Investigations are underway. The sudden simultaneous emergence of monkeypox in many countries suggests there may have been hidden transmission for a long period,” Tedros Adhanom Ghebreyesus, WHO’s director-general, informed journalists at its Geneva headquarters.
With most cases occurring during sexual interactions between men, these communities are educating their members about safety and preventative measures that can be taken.
“We all must work hard to combat stigma, which is not only incorrect but also has the potential to hinder infected people from seeking treatment and making it more difficult to stop the epidemic,” said the WHO chief while encouraging impacted nations to broaden their watch to the wider community.